Competitive upconversion-linked immunoassay using peptide mimetics for the detection of the mycotoxin zearalenone

Authors: R. Peltomaa, Z. Farka, M.J. Mickert, J.C. Brandmeier, M. Pastucha, A. Hlavá?ek, M. Martínez-Orts, Á. Canales, P. Skládal, E. Benito-Peña, M.C. Moreno-Bondi, H.H. Gorris

Publication: Biosens. Bioelectron.

Year: 2020 Volume: 170 Pages: 112683 to 112691

[Check out this article at Pubmed] 

 

Efficient chemoenzymatic synthesis of N-glycans with a beta-1,4-galactosylated bisecting GlcNAc motif

Authors: M. Weiss, D. Ott, T. Karagiannis, M. Weishaupt, M. Niemietz, S. Eller, M. Lott, M. Martínez-Orts, Á. Canales, N. Razi, J.C. Paulson, C. Unverzagt

Publication: ChemBioChem

Year: 2020 Volume: 21 Pages: 3212 to 3215

[Check out this article at Pubmed] 

 

Glucose metabolism links astroglial mitochondria to cannabinoid effects

Authors: D. Jimenez-Blasco, A. Busquets-Garcia, E. Hebert-Chatelain, R. Serrat, C. Vicente-Gutierrez, C. Ioannidou, P. Gómez-Sotres, I. Lopez-Fabuel, M. Resch-Beusher, E. Resel, D. Arnouil, D. Saraswat, M. Varilh, A. Cannich, F. Julio-Kalajzic, I. Bonilla-Del Río, A. Almeida, N. Puente, S. Achicallende, M.L. López-Rodríguez, C. Jollé, N. Déglon, L. Pellerin, C. Josephine, G. Bonvento, A. Panatier, B. Lutz, P.-V. Piazza, M. Guzmán, L. Bellocchio, A.-K. Bouzier-Sore, P. Grandes, J.P. Bolaños, G. Marsicano

Publication: Nature

Year: 2020 Volume: 583 Pages: 603 to 608

[Check out this article at Pubmed] 

 

A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration

Authors: I. Gonzalez-Gil, D. Zian, H. Vázquez-Villa, G. Hernandez-Torres, R.F. Martinez, N. Khiar-Fernandez, R. Rivera, Y. Kihara, I. Devesa, S. Mathivanan, C. Rosell del Valle, E. Zambrana-Infantes, M. Puigdomenech, G. Cincilla, M. Sanchez-Martinez, F. Rodriguez de Fonseca, A. Ferrer-Montiel, J. Chun, R. Lopez-Vales, M.L. López-Rodríguez, S. Ortega-Gutierrez

Publication: J. Med. Chem.

Year: 2020 Volume: 63 Pages: 2372 to 2390

[Check out this article at Pubmed] 

 

Serum endocannabinoid levels in suicide attempters: A pilot study

Authors: J. Herranz-Herrer, E. Gil-Benito, T. Ponte-López, S. Ortega-Gutiérrez, J. Macicior, S. Rosado-Garcia, A.J. Sánchez-López, H. Blasco-Fontecilla

Publication: Eur. Neuropsychopharmacol.

Year: 2020 Volume: 40 Pages: 52 to 60

[Check out this article at Pubmed] 

 

Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer action of FASN inhibitors: a multi-omics analysis in ovarian cancer

Authors: T.W. Grunt, A. Slany, M. Semkova, R. Colomer, M.L. López-Rodríguez, M. Wuczkowski, R. Wagner, C. Gerner, G. Stübiger

Publication: Sci. Rep.

Year: 2020 Volume: 10 Pages: 14877 to 14887

[Check out this article at Pubmed] 

 

The cannabinoid WIN55212-2 restores rhinovirus-induced epithelial barrier disruption

Authors: A. Angelina, M. Martín-Fontecha, B. Rückert, P. Wawrzyniak, M. Pérez-Diego, J. López-Abente, M. Akdis, C.A. Akdis, O. Palomares

Publication: Allergy

Year: 2021 Volume: 76 Pages: 1900 to 1902

[Check out this article at Pubmed] 

 

Chemistry for the identification of therapeutic targets: Recent advances and future directions

Authors: N. Khiar-Fernandez, J. Macicior, B. Marcos-Ramiro, S. Ortega-Gutierrez

Publication: Eur. J. Org. Chem.

Year: 2021 Volume: 2021 Pages: 1307 to 1320

[Check out this article at Pubmed] 

 

The pharmacological or genetic blockade of endogenous de novo fatty acid synthesis does not increase the uptake of exogenous lipids in ovarian cancer cells

Authors: T.W. Grunt, L. Lemberger, R. Colomer, M.L. López-Rodríguez, R. Wagner

Publication: Front. Oncol. doi: 10.3389/fonc.2021.610885

Year: 2021 Volume: 11 Pages: 610885 to 610895

[Check out this article at Pubmed] 

 

Targeting the FtsZ allosteric binding site with a novel fluorescence polarization screen, cytological and structural approaches for antibacterial discovery

Authors: S. Huecas, L. Araújo-Bazán, F.M. Ruiz, L.B. Ruiz-Ávila, R.F. Martínez, A. Escobar-Peña, M. Artola, H. Vázquez-Villa, M. Martín-Fontecha, C. Fernández-Tornero, M.L. López-Rodríguez, J.M. Andreu

Publication: J. Med. Chem.

Year: 2021 Volume: 64 Pages: 5730 to 5745

[Check out this article at Pubmed] 

 

Small-molecule therapeutic perspectives for the treatment of progeria

Authors: J. Macicior, B. Marcos-Ramiro, S. Ortega-Gutiérrez

Publication: Int. J. Mol. Sci.

Year: 2021 Volume: 22 Pages: 7190 to 7200

[Check out this article at Pubmed] 

 

Isoprenylcysteine carboxylmethyltransferase-based therapy for Hutchinson–Gilford progeria syndrome

Authors: B. Marcos-Ramiro, A. Gil-Ordóñez, N.I. Marín-Ramos, F. J. Ortega-Nogales, M. Balabasquer, P. Gonzalo, N. Khiar-Fernández, L. Rolas, A. Barkaway, S. Nourshargh, V. Andrés, M. Martín-Fontecha, M.L. López-Rodríguez, S. Ortega-Gutiérrez

Publication: ACS Cent. Sci.

Year: 2021 Volume: 8 Pages: 1300 to 1310

[Check out this article at Pubmed] 

 

The search for antibacterial inhibitors targeting cell division protein FtsZ at its nucleotide and allosteric binding sites

Authors: J.M. Andreu, S. Huecas, L. Araújo-Bazán, H. Vázquez-Villa, M. Martín-Fontecha

Publication: Biomedicines

Year: 2022 Volume: 10 Pages: 1825 to 1837

[Check out this article at Pubmed] 

 

Discovery of V-0219: A small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptor toward oral treatment for “Diabesity”

Authors: J.M. Decara, H. Vázquez-Villa, J. Brea, M. Alonso, R.K. Srivastava, L. Orio, F. Alén, J. Suárez, E. Baixeras, J. García-Cárceles, A. Escobar-Peña, B. Lutz, R. Rodríguez, E. Codesido, F.J. Garcia-Ladona, T.A. Bennett, J.A. Ballesteros, J. Cruces, M.I. Loza, B. Benhamú, F. Rodríguez de Fonseca, M.L. López-Rodríguez

Publication: J. Med. Chem.

Year: 2022 Volume: 65 Pages: 5449 to 5461

[Check out this article at Pubmed] 

 

New trends in aging drug discovery

Authors: B. Benhamú, M. Martín-Fontecha, H. Vázquez-Villa, M.L. López-Rodríguez, S. Ortega-Gutiérrez

Publication: Biomedicines

Year: 2022 Volume: 10 Pages: 2006 to 2039

[Check out this article at Pubmed] 

 

Novel antagonist of the type 2 lysophosphatidic acid receptor (LPA2), UCM-14216, ameliorates spinal cord injury in mice

Authors: N. Khiar-Fernández, D. Zian, H. Vázquez-Villa, R.F. Martínez, A. Escobar-Peña, R. Foronda-Sainz, M. Ray, M. Puigdomenech-Poch, G. Cincilla, M. Sánchez-Martínez, Y. Kihara, J. Chun, R. López-Vales, M.L. López-Rodríguez, S. Ortega-Gutiérrez

Publication: J. Med. Chem. doi: 10.1021/acs.jmedchem.2c00046

Year: 2022 Volume: 0 Pages: 0 to 0

[Check out this article at Pubmed] 

 

2-(Fluoromethoxy)-4'-(S-methanesulfonimidoyl)-1,1?-biphenyl (UCM-1306), an orally bioavailable positive allosteric modulator of the human dopamine D1 receptor for Parkinson’s disease

Authors: J. García-Cárceles, H. Vázquez-Villa, J. Brea, D. Ladron de Guevara-Miranda, G. Cincilla, M. Sánchez-Martínez, A. Sánchez-Merino, S. Algar, M.T. de los Frailes, R.S. Roberts, J.A. Ballesteros, F. Rodríguez de Fonseca, B. Benhamú, M.I. Loza, M.L. López-Rodríguez
Publication: J. Med. Chem. doi: 10.1021/acs.jmedchem.2c00949
Year: 2022 Volume: 0 Pages: 0 to 0